This is followed by an afternoon of established names including China Crisis, Amsterdam and John Head from Shack, finishing with a set by 1960s group The Merseybeats.
After Cordaptive was rejected, Merck canceled a trial of the drug run by the same outside scientist--John Kastelein of the University of Amsterdam--who ran the Vytorin trial.
In an interview Friday, John Kastelein of the University of Amsterdam, the lead outside scientist conducting the trial, says he was not consulted about the timeline or the press release before it was issued.